Enzymatic Degradation of GlycosaminogIycans

References

• Allen J. D. Subsite mapping of enzymes: application to polysaccharide depolymerases. Meth. Enymol. 1980; 64: 248–77
   PubMedGoogle Scholar
• Ampofo S. A., Wang H. M., Linhardt R. J. Disaccharide compositional analysis of heparin and heparan sulfate using capillary zone electrophoresis. Anal. Biochem. 1991; 199: 249–55
   PubMed Web of Science ®Google Scholar
• Amott S., Guss J. M., Hukins D. W. L. Conformation of keratan sulphate. J. Mol. Biol. 1974; 88: 175–84
   Google Scholar
• Ascencio F., Fransson L.-A., Wadstrom T. Affinity of the gastric pathogen Helicobacter pylorifor the N-sulphated glycosaminoglycan heparan sulphate. J. Med. Microbiol. 1993; 38: 240–44
   PubMedGoogle Scholar
• Atha D. H., Lormeau J.-C., Petitou M., Rosenberg R. D., Choay J. Contribuiton of monosaccharide residues in heparin binding to antithrombin III. Biochemistry 1985; 24: 6723–29
   PubMed Web of Science ®Google Scholar
• Atkins E. D. T., Nieduszynski I. A. Heparin: crystalline structures of the sodium and calcium salts. Heparin — Chemistry and Clinical Usage., V. V. Kakkar, D. P. Thomas. Academic Press, London 1976; 21–35
   Google Scholar
• Bailey J. E., Ollis D. F. Biochemical Engineering Fundamentals. McGraw-Hill, New York 1986
   Google Scholar
• Balduini C., De Luca G., Castellani A. A. Biosynthesis of skeletal and corneal keratan sulphate. Keratan Sulphate — Chemistry, Biology, Clinical Pathology., H. Greiling, J. E. Scott. The Biochemical Society, London 1989; 53–65
   Google Scholar
• Bame K. J. Release of heparan sulfate glycosami-noglycans from proteoglycans in Chinese hamster ovary cells does not require proteolysis of the core protein. J. Biol. Chem. 1993; 268: 19956–64
   Google Scholar
• Baugh R. F., Deemar K. A., Zimmerman J. J. Heparinase in the activated clotting time assay: monitoring heparin-independent alterations in coagulation function. Anesth. Analg. 1992; 74: 201–05
   Google Scholar
• Bellamy R. W., Horikoshi K. Heparinase produced by a microorganism belonging to the genus Bacillus. United States Patent 1992; 5: 145, 778
   Google Scholar
• Bellamy W. R. A novel Bacillussp. capable of degrading sulfated glycosaminoglycans. Superbugs, Microorganisms in Extreme Environments., K. Horikoshi, W. D. Grant. Japan Scientific Societies Press, Tokyo 1990; 143–57
   Google Scholar
• Belshaw N. J., Williamson G. Specificity in the binding domain of glucoamylase 1. Eur. J. Biochem. 1993; 211: 717–24
   PubMedGoogle Scholar
• Bitter T., Muir H. M. A modified uronic acid carbazole reaction. Anal Biochem 1962; 4: 330–34
   PubMed Web of Science ®Google Scholar
• Böhmer L. H., Pitout M. J., Steyn P. L., Visser L. Purification and characterization of a novel heparinase. J. Biol. Chem. 1990; 265: 13609–17
   PubMed Web of Science ®Google Scholar
• Bourin M.-C., Lindahl U. Glycosaminoglycans and the regulation of blood coagulation. Biochem. J. 1993; 289: 313–30
   PubMed Web of Science ®Google Scholar
• Bourin M.-C., Lundgren-Åkerlund E., Lindahl U. Isolation and characterization of the glycosaminoglycan component of rabbit thrombomodulin proteoglycan. J. Biol. Chem. 1990; 265: 15424–431
   Google Scholar
• Cael J. J., Winter W. T., Amott S. Calcium chondroitin 4-sulfate: Molecular conformation and organization of polysaccharide chains in a proteoglycan. J. Mol. Biol. 1978; 125: 21–42
   PubMed Web of Science ®Google Scholar
• Cardin A. D., Demeter D. A., Weintraub H. J. R., Jackson R. L. Molecular design and modeling of protein-heparin interactions. Meth. Enzymol. 1991; 203: 556–583
   Google Scholar
• Cardin A. D., Weintraub H. J. R. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 1989; 9: 21–32
   PubMedGoogle Scholar
• Casu B. Structure of heparin and heparin fragments. Ann. N. Y. Acad. Sci. 1989; 556: 1–17
   PubMed Web of Science ®Google Scholar
• Casu B., Choay J., et al. Controversial glycosaminoglycan conformations. Nature 1986; 322: 215–16
   PubMed Web of Science ®Google Scholar
• Casu B., Petitou M., Provasoli M., Sinay P. Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans. TZBS 1988; 13: 221–25
   Google Scholar
• Celesia G. G. Alzheimer's desease: the proteoglycans hypothesis. Sem. Thromb. Hem. 1991; 17(suppl 2)158–60
   Google Scholar
• Cerbelaud E. C., Conway L. J., Galliher P. M., Langer R. S., Cooney C. L. Sulfur regulation of heparinase and sulfatases in Flavobacterium heparinum. Appl. Env. Micr. 1986; 51: 640–46
   Google Scholar
• Cheng F., Yoshida K., Heinegård D., Fransson L.-Å. A new method for sequence analysis of glycosaminoglycans from heavily substituted proteoglycans reveals non-random positioning of 4– and 6–0-sulphated N-acetylgalactosamine in aggrecan-derived chondroitin sulphate. Clycobidlogy. 1992; 2: 553–61
   Google Scholar
• Cohen D. M., Linhardt R. J. Randomness in the heparin polymer: Computer simulations of alternative action patterns of heparin lyase. Biopolymers 1990; 30: 733–41
   Google Scholar
• Cohen F. E. The parallel p helix of pectate lyase C: something to sneeze at. Science 1993; 260: 1444–45
   PubMedGoogle Scholar
• Coltrini D., Rusnati M., et al. Biochemical bases of the interaction of human basic fibroblast growth factor with the glycosaminoglycans. Eur. J. Biochem. 1993; 214: 51–58
   PubMedGoogle Scholar
• Comper W. D. Heparin (and related polysaccha-rides. Gordon & Breach, New York 1981
   Google Scholar
• Conrad H. E. Structure of heparan sulfate and dermatan sulfate. Ann. N.Y. Acad. Sci. 1989; 556: 18–28
   PubMed Web of Science ®Google Scholar
• Creighton T. E. Proteins: Structures and Molecular Properties (2. ed.). W.H. Freeman and Co., New York 1993
   Google Scholar
• D'Amore P. A. Modes of FGF release in vivo and in vitro. Cancer and Metastasis Reviews 1990; 9: 227–38
   PubMed Web of Science ®Google Scholar
• de Agostini A. L., Lau H. K., Leone C., Youssoufian H., Rosenberg R. D. Cell mutants defective in synthesizing a heparan sulfate proteoglycan with regions of defined monosaccharide sequence. Proc. Natl. Acad. Sci., USA 1990; 87: 9784–88
   Google Scholar
• Desai U. R., Wang H., Linhardt R. J. Specificity studies on the heparin lyases from Flavobacterium heparinum. Biochemistry 1993a; 32: 8140–45
   Google Scholar
• Desai U. R., Wang H., Linhardt R. J. Substrate specificity of the heparin lyases from Flavobacterium heparinurn. Arch. Biochem. Biophys. 1993b; 306: 461–68
   PubMedGoogle Scholar
• Dietrich C. P., Silva M. E., Michelacci Y. M. Sequential degradation of heparin in Flavobacterium heparinum. J. Biol. Chem. 1973; 248: 6408–15
   Google Scholar
• Engelberg H. Heparin, non-heparin glycosaminogly-cans, and heparinoids: An overview of their application in atherosclerosis. Sem Thromb. Hem. 1991; 17(suppl 1)5–8
   Google Scholar
• Enghild J. J., Salvesen G., Hefta S. A., Thagersen I. B., Rutherford S., Pizzo S. V. Chondroitin 4-sulfate covalently cross-links the chains of the human blood protein pre-a-inhibitor. J. Biol. Chem 1991; 266: 747–51
   PubMed Web of Science ®Google Scholar
• Eriksson A. E., Cousens L. S., Weaver L. H., Matthews B. W. Three-dimensional structure of human basic fibroblast growth factor. Proc. Natl. Acad. Sci., USA 1991; 88: 3441–45
   PubMed Web of Science ®Google Scholar
• Ernst S., Venkataraman G., Winkler S., Godavarti R., Langer R., Cooney C. L., Sasisekharan R. Expression, purification, and characterization of heparinase I from F. heparinumin E. coli. Submitted to. Biochemical J. 1995
   Google Scholar
• Evered D., Whelan J. Functions of the Proteoglycans. John Wiley & Sons, Chichester, NY 1986
   Google Scholar
• Evered D., Whelan J. The Biology of Hyaluronan. John Wiley & Sons, Chichester, NY 1989
   Google Scholar
• Fedarko N. S., Conrad H. E. A unique heparan sulfate in the nuclei of hepatocytes: Structural changes with the growth state of the cells. J. Cell. Biol. 1986; 102: 587–99
   PubMed Web of Science ®Google Scholar
• Ferro D. R., Provasoli A., et al. Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences. Curb. Res. 1990; 195: 157–67
   PubMed Web of Science ®Google Scholar
• Ferro D. R., Provasoli A., Ragazzi M., Meille S. V., Colombo A. On the solid-state conformation of glycosaminoglycans containing iduronic acid. International workshop on recent developments in industrial polysaccharides., V. Crescenzi. Gordon and Breach, New York 1989
   Google Scholar
• Fersht A. Entyme Structure and Mechanism (2. ed.). W.H. Freeman and Co, New York 1985
   Google Scholar
• Folkman J., Klagsbrun M. Angiogenic Factors. Science 1987; 235: 442–47
   PubMed Web of Science ®Google Scholar
• Fransson L.-Å. Mammalian Glycosaminoglycans. The Polysaccharides., G. O. Aspinall. Academic Press, Orlando, FL 1985
   Google Scholar
• Fransson L.-Å., Cöster L. Interaction between dermatan sulphate chains. Biochim. Biophys. Acta 1979; 582: 132–44
   PubMed Web of Science ®Google Scholar
• Fransson L.-Å., Havsmark B., Sheehan J. K. Self-associatin of heparan sulfate. J. Biol. Chem. 1981; 256: 13039–43
   PubMed Web of Science ®Google Scholar
• Fransson L.-Å., Havsmark B., Silverberg I. A method for the sequence analysis of dermatan sulphate. Biochem. J. 1990; 269: 381–388
   PubMed Web of Science ®Google Scholar
• French A. D., Brady J. W. Computer modeling of carbohydrates. ACS Symposium Series 1990; 430: 1–19
   Google Scholar
• Gabriel D. A., Carr M. E. Calcium destabilizes and causes conformational changes in hyaluronic acid. Am. J. Med. Sci. 1989; 298: 8–14
   Google Scholar
• Gallagher J. T., Lyon M., Steward W. P. Structure and function of heparan sulphate proteoglycans. Biochem. J. 1986; 236: 313–25
   PubMed Web of Science ®Google Scholar
• Gallagher J. T., Turnbull J. E., Lyon M. Hepm sulphate proteoglycans: molecular organisation of membrane-associated species and an approach to polysac-charide sequence analysis. Heparin and related polysaccharides., D. A. Lane, I. Björk, U. Lindahl. Plenum Press, New York 1992a
   Google Scholar
• Gallagher J. T., Turnbull J. E., Lyon M. Patterns of sulphation in heparan sulphate: polymorphism based on a common structural theme. Int. J. Biochem. 1992b; 24: 553–60
   Google Scholar
• Gallagher J. T., Walker A. Molecular distinctions between heparan sulphate and heparin. Biochem. J. 1985; 230: 665–74
   PubMed Web of Science ®Google Scholar
• Gettins P., Home A. P. One- and two-dimensional 13 C-n.m.r characterization of two series of oli-gosaccharides derived from porcine intestinal mucosal heparin by degradation with heparinase. Carb. Res. 1992; 223: 81–98
   Google Scholar
• Gitay-Goren H., Soker S., Vlodavsky I., Neufeld G. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem. 1992; 267: 6093–98
   PubMed Web of Science ®Google Scholar
• Godder K., Vlodavsky I., Eldor A., Weksler B. B., Haimonvitz-Friedman A., Fuks Z. Heparanase activity in cultured endothelial cells. J. Cell. Physiol. 1991; 148: 274–80
   Google Scholar
• Gospodarowicz D., Cheng J. Heparin protects basic and acidic FGF from inactivation. J. Cell. Phys. 1986; 128: 475–84
   PubMed Web of Science ®Google Scholar
• Greiling H., Scott J. E. Keratan Sulphate —Chemistry, Biology, Clinical Pathology. The Biochemical Society, London 1989
   Google Scholar
• Greiling H., Stuhlsatz W., Eberhard T., Eberhard A. Studies on the mechanism of hyaluronate lyase action. Conn. Tissue Res. 1975; 3: 135–39
   PubMed Web of Science ®Google Scholar
• Grootenhuis P. D. J., van Boeckel C. A. A. Constructing a molecular model of the interaction between antithrombin III and a potent heparin analogue. J. Am. Chem. Soc. 1991; 113: 2743–47
   Web of Science ®Google Scholar
• Grootenhuis P. D. J., van Boeckel C. A. A., Haasnoot C. A. G. Carbohydrates and drug discovery —the role of computer simulation. TIBTECH. 1994; 12: 9–14
   Google Scholar
• Gu K., Edens R. E., Jandik K. A., Linhardt R. J. Monoclonal antibodies prepared against heparin lyase I and their reactivity toward heparin lyase I, II, and III. Int. J. Biochem. 1993a; 25: 331–36
   Google Scholar
• Gu K., Liu J., Pervin A., Linhardt R. J. Comparison of the activity of two chondroitin AC lyases on dermatan sulfate. Curb. Res. 1993b; 244: 369–77
   Google Scholar
• Guimond S., Maccarana M., Olwin B. B., Lindahl U., Rapraeger A. C. Activating and inhibitory heparin sequences for FGF-2 (Basic FGF). J. Biol. Chem. 1993; 268: 23906–14
   PubMed Web of Science ®Google Scholar
• Guo Y., Conrad H. E. The disaccharide composition of heparins and heparan sulfates. Anal. Biochem. 1989; 176: 96–104
   Google Scholar
• Guss J. M., Hukins D. W. L., et al. Hyaluronic acid: molecular conformations and interactions in two sodium salts. J. Mol. Biol. 1975; 95: 359–84
   PubMed Web of Science ®Google Scholar
• Guthrie E. P., Shoemaker N. B., Salyers A. A. Cloning and expression in Escherichia coliof a gene coding for a chondroitin lyase from Bacreroides thetaiotaomicron. J. Bactacteriology 1985; 164: 510–15
   Google Scholar
• Haasnoot C. A. G. The conformation of six-mem-bered rings described by puckering coordinates derived from endocyclic torsion angles. J. Am. Chem. Soc. 1992; 114: 882–87
   Web of Science ®Google Scholar
• Habuchi H., Suzuki S., et al. Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor. Biochem. J. 1992; 285: 805–13
   Google Scholar
• Hamai A., Morikawa K., Hone K., Tokuyasu K. Purification and characterization of hyaluronidase from Streptococcus dysgalactiae. Agric. Biol. Chem. 1989; 53: 2163–68
   Web of Science ®Google Scholar
• Hardingham T. E., Fosang A. J. Proteoglycans: many forms and many functions. FASEB J 1992; 6: 861–70
   PubMed Web of Science ®Google Scholar
• Hart G. W. Glycosylation. Curr. Op. Cell. Biol 1992; 4: 1017–23
   PubMedGoogle Scholar
• Hascall V. C., Midura R. J. Keratan sulphate proteoglycans: chemistry biosynthesis of linkage regions. Keratan Sulphate — Chemistry, Biology, Clinical Pathology., H. Greiling, J. E. Scott. The Biochemical Society, London 1989; 66–73
   Google Scholar
• Hay E. D. Cell Biology of Extracellular Matrix (2nd ed.). Plenum Press, New York 1991
   Google Scholar
• Heatley F., Scott J. E. A water molecule participates in the secondary structure of hyaluronan. Biochem. J. 1988; 254: 489–93
   PubMed Web of Science ®Google Scholar
• Highsmith S., Garvin J. H., Chipman D. M. Mechanism of action of bovine testicular hyaluronidase. J Biol Chem 1975; 250: 7473–80
   PubMed Web of Science ®Google Scholar
• Hinton J. C. D., Sidebotham D. R., Gill G. P., Solmond C. Mol. Microbiology 1989; 3: 1785
   PubMed Web of Science ®Google Scholar
• Hirsch J. Heparin. N. Eng. J. Med. 1991; 324: 1565–74
   Google Scholar
• Hiyama K., Okada S. Amino Acid composition and physicochemical characterization of chondroitinase from Arthrobacter aurescens. J. Biochem. 1975a; 78: 1183–90
   Google Scholar
• Hiyama K., Okada S. . Crystallization and some properties of chondroitinase from Arthrobacter aurescens. J. Biol. Chem. 1975b; 250: 1824–28
   PubMed Web of Science ®Google Scholar
• Hiyama K., Okada S. Action of Chondroitinases I. J Biochem 1976; 80: 1201–07
   Google Scholar
• Hiyama K., Okada S. Action of Chondroitinases III. J Biochem 1977; 82: 429–36
   Google Scholar
• Hopwood J. J. Enzymes that degrade heparin and heparan sulphate. Heparin. — Chemical and biological properties clinical applications., D. A. Lane, U. Lindahl. CRC Press, Boca Raton 1989
   Google Scholar
• Hounsell E. F. Structural and conformational analysis of kentan sulphate oligosaccharides and related carbohydrate structures. Keratan Sulphate — Chemistry. Biology, Clinical Pathology., H. Greiling, J. E. Scott. The Biochemical Society, London 1989; 12–15
   Google Scholar
• Hounsell E. F., Feeney J., Scudder P., Tang P. W., Feizi T. 1H-NMR studies at 500 MHz of a neutral disaccharide and sulphated di-, tetra-, hexa-, and larger oligosaccharides obtained by endo-β-galactosidase treatment of keratan sulphate. Eur. J. Biochem. 1986; 157: 375–84
   Google Scholar
• Hunter G. K., Wong K. S., Kim J. J. Binding of calcium to glycosaminoglycans: an equilibrium dialysis study. Arch. Biochem. Biophys. 1988; 260: 161–67
   PubMed Web of Science ®Google Scholar
• Hwa V., Salyers A. A. Analysis of two chondroitin sulfate utilization mutants of Bacteroides thetaiotamicronthat differ in their abilities to compete with the wild type in the gastrointestinal tracts of germfree mice. Appl. Env. Micr. 1992; 58: 869–76
   Google Scholar
• Ingber D. E. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: Role of extracellular matrix. J. Cell. Biol. 1989; 109: 317–30
   PubMed Web of Science ®Google Scholar
• Isaacs R. D. Borrelia burgdorferibind to epithelial cell proteoglycans. J. Clin. Invest. 1994; 93: 809–19
   PubMedGoogle Scholar
• Ishai-Michaeli R., Eldor A., Vlodavsky I. Heparanase activity expressed by platelets, neutrophils and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regulation 1990; 1: 833–42
   PubMedGoogle Scholar
• Isihara M., Fedarko N. S., Conrad H. E. Transport of heparan sulfate into the nuclei of hepatocytes. J. Biol. Chem. 1986; 261: 13575–80
   Google Scholar
• Isihara M., Fedarko N. S., Conrad H. E. Involvement of phosphatidylinositol and insulin in the coordinate regulation of proteoheparan sulfate metabolism and hepatocyte growth. J. Biol. Chem. 1987; 262: 4708–16
   Google Scholar
• Isihara M., Tyrrell D. J., Stauber G. B., Brown S., Cousens L. S., Stack R. J. Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. J. Biol. Chem. 1993; 268: 4675–83
   Google Scholar
• Itoh K., Sokol S. Y. Heparan sulfate proteoglycans are required for mesoderm formation in Xenopusembryos. Development 1994; 120: 2703–11
   Google Scholar
• Jackson R. L., Busch S. J., Cardin A. D. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiological Reviews 1991; 71: 481–539
   PubMed Web of Science ®Google Scholar
• Jandik K. A., Gu K., Linhardt R. J. Action patterns of polysaccharide lyases on glycosaminoglycans. Glycobiology 1994; 4: 289–96
   PubMed Web of Science ®Google Scholar
• Jaye M., Schlessinger J., Dionne C. A. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim. Biophys. Acta 1992; 1135: 185–99
   PubMed Web of Science ®Google Scholar
• Jencks W. P. On the attribution and additivity of binding energies. Proc. Natl. Acad. Sci., USA 1981; 78: 4046–50
   PubMed Web of Science ®Google Scholar
• Jouben J. J., Pitout M. J. A constitutive heparinase in a Flavobacteriumsp. Experientia 1985; 41: 1541
   Google Scholar
• Juhasz P., Biemann K. Mass spectrometric molecular weight determination of highly acidic compounds of biological significance via their complexes with basic polypeptides. Proc. Natl. Acad. Sci., USA 1994; 91: 4333–37
   Google Scholar
• Kan M., Wang F., Xu J., Crabb J. W., Hou J., McKeehan W. L. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 1993; 259: 1918–21
   PubMed Web of Science ®Google Scholar
• Kemeney D. M., Dalton N., Lawrence A. J., Pearce F. L., Vernon C. A. The purification and characterization of hyaluronidase from the venom of the honey bee, Apis mellifera. Eur. J. Biochem. 1984; 139: 217–23
   PubMedGoogle Scholar
• Kiefer M. C., Ishihara M., Swiedler S. J., Crawford K., Stephans J. C., Barr P. J. The molecular biology of heparan sulfate fibroblast growth factor receptors. Ann. N.Y. Acad. Sci. 1991; 556
   Google Scholar
• Kirby A. J. Mechanism and stereoelectronic effects in the lysozyme reaction. CRC Cnt. Rev. Biochem. 1987; 22: 283–312
   Web of Science ®Google Scholar
• Kitamikado M., Lee Y.-Z. Chondroitinase-pro-ducing bacteria in natural habitats. Appl. Microbiol. 1975; 29: 414–21
   PubMedGoogle Scholar
• Kjellbn L., Lindahl U. Proteoglycans: structures and interactions. Ann. Rev. Biochem. 1991; 60: 443–75
   Google Scholar
• Klagsbrun M., Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 1991; 67: 229–31
   PubMed Web of Science ®Google Scholar
• Kojima T., Leone C. W., Marchildon G. A., Marcum J. A., Rosenberg R. D. Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells. J. Biol. Chem. 1992; 267: 4859–69
   Google Scholar
• Kresse H. Degradation of keratan sulphate proteoglycans. Keratan Sulphate — Chemistry, Biology, Clinical Puthology., H. Greiling, J. E. Scott. The Biochemical Society, London 1989; 111–121
   Google Scholar
• Kresse H., Glossl J. Glycosaminoglycan degradation. Adv. Enzym. 1987; 60: 217–312
   Google Scholar
• Kvam B. J., Atzori M., Toffanin R., Paoletti S., Biviano F. 1H and 13C NMR studies of solutions of hyaluronic acid esters and salts in methyl sulfoxide: comparison of hydrogen-bond patterns and conformational behaviour. Carb. Res. 1992; 230: 1–13
   PubMed Web of Science ®Google Scholar
• Lane D. A., Lindahl U. Heparin — chemical and biological properties clinical applications. CRC Press, Boca Raton 1989
   Google Scholar
• Langer R., Linhardt R. J., et al. An enzymatic system for removing heparin in extracorporeal therapy. Science 1982; 217: 261–63
   PubMed Web of Science ®Google Scholar
• Laskov R., Michaeli R. I., Sharir H., Yefenof E., Vlodavsky I. Production of heparanase by normal and neoplastic murine B-lymphocytes. Inr. J. Cancer 1991; 47: 92–98
   PubMed Web of Science ®Google Scholar
• Lee M. K., Lander A. D. Analysis of affinity and structural selectivity in the binding of proteins to gly-cosaminoglycans: development of a sensitive electro-phoretic approach. Proc. Natl. Acad. Sci., USA 1991; 88: 2768–72
   Google Scholar
• Lindahl U. Biosynthesis of heparin and related polysac-charides. Heparin — Chemical and biological properties clinical applications. 1989; 159–91
   Google Scholar
• D. A. Lane, U. Lindahl. CRC Press, Boca Raton
   Google Scholar
• Lindahl U., Kusche M., Lidholt K., Oscarrson L.-G. Biosynthesis of heparin and heparan sulfate. Ann. N. Y. Acad. Sci. 1989; 556: 36–50
   PubMed Web of Science ®Google Scholar
• Lindahl U., Lidholt K., Spillmann D., Kjellén L. More to “heparin” than anticoagulation. Thrombosis Research 1994; 75: 1–32
   PubMed Web of Science ®Google Scholar
• Lindahl U., Thinberg L., Bäckstrom G., Riesenfeld J., Nordling K., Björk I. Extension and smctural variability of the antithrombin-binding sequence in heparin. J. Biol. Chem. 1984; 259: 12368–76
   PubMedGoogle Scholar
• Lindblom A., Bengtsson-Olivecrona G., Fransson L.-Å. Domain structure of endothelial heparan sulphate. Biochem. J. 1991; 279: 821–29
   Google Scholar
• Linhardt R. J. Analysis of glycosaminoglycans with polysaccharide lyases. Current Protocols in Molecular Biology, Chapter 17 suppl., A Varki, 1994
   Google Scholar
• Linhardt R. J., Al-hakim A., et al. Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities. Biochem. Pharm. 1991; 42: 1609–19
   Google Scholar
• Linhardt R. J., Ampofo S. A., Fareed J., Hoppensteadt D., Mulliken J. B., Folkman J. Isolation and characterization of human heparin. Biochemistry 1992; 31: 12441–45
   PubMed Web of Science ®Google Scholar
• Linhardt R. J., Fitzgerald G. L., Cooney C. L., Langer R. Mode of action of heparin lyase on heparin. Biochim. Biophys. Acta. 1982; 702: 197–203
   PubMedGoogle Scholar
• Linhardt R. J., Galliher P. M., Cooney C. L. Polysaccharide lyases. Appl. Biochem. Biotech. 1986; 12: 135–75
   PubMed Web of Science ®Google Scholar
• Linhardt R. J., Merchant Z. M., et al. Evidence of random structural features in the heparin polymer. Biochemistry 1985; 24: 7805–10
   Google Scholar
• Linhardt R. J., Rice K. G., Kim Y. S., Engelken J. D., Weiler J. M. Homogeneous, structurally defined heparin-oligosaccharides with low anticoagulant activity inhibit the generation of the amplification pathway C3 convertase in vitro. J. Biol. Chem. 1988a; 263: 13090–96
   PubMed Web of Science ®Google Scholar
• Linhardt R. J., Rice K. G., Kim Y. S., Lohse D. L., Wang H. M., Loganathan D. Mapping and quantification of the major oligosaccharide components of heparin. Biochem. J. 1988b; 254: 781–87
   PubMed Web of Science ®Google Scholar
• Linhardt R. J., Turnbull J. E., Wang H. M., Loganathan D., Gallagher J. T. Examination of the substrate specificity of heparin and heparan sulfate lyases. Biochemistry. 1990; 29: 2611–17
   PubMedGoogle Scholar
• Linhardt R. J., Wang H.-M., Loganathan D., Bae J.-H. Search for the heparin antithrombin III-binding precursor. J. Biol. Chem. 1992a; 267: 2380–87
   Google Scholar
• Linhardt R. J., Wang H. M., Ampofo S. A. New methodologies in heparin structure analysis and the generation of LMW heparins. Heparin and related polysaccharides., D. A. Lane, I. Bjork, U. Lindahl. Plenum Press, New York 1992b
   Google Scholar
• Linker A., Hovingh P. Heparinase and heparitinase from Flavobacteria. Meth. Enzymol. 1972; 28: 902–11
   Google Scholar
• Linn S., Chan T., Lipeski L., Salyers A. A. Isolation and characterization of two chondroitin lyases from Bacteroides thetaiotamicron. J Bacteriology 1983; 156: 859–66
   PubMed Web of Science ®Google Scholar
• Loganathan D., Wang H. M., Mallis L. M., Linhardt R. J. Structural variation in the antithrombin III binding site region and its occurence in heparin from different sources. Biochemistry 1990; 29: 4362–68
   PubMedGoogle Scholar
• Lohse D. L., Linhardt R. J. Purification and characterization of heparin lyases from Flavobacterium heparinum. J. Biol. Chem. 1992; 267: 23347–55
   Google Scholar
• Lortat-Jacob H., Grimaud J.-A. Binding of inter-feron-gammma to heparan sulfate is restricted to the heparin-like domains and involves carboxylic — but not N-sulfated— groups. Biochim. Biophys. Acta 1992; 1117: 126–30
   Google Scholar
• Lyon M., Deakin J. A., Mizuno K., Nakamum T., Gallagher J. T. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J. Biol. Chem. 1994; 269: 11216–23
   PubMed Web of Science ®Google Scholar
• Maccarana M., Casu B., Lindahl U. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J. Biol. Chem. 1993; 268: 23898–905
   PubMed Web of Science ®Google Scholar
• MacGregor E. A., MacGregor A. W. A model for the action of cereal alpha amylases on amylose. Carb. Res. 1985; 142: 223–36
   Web of Science ®Google Scholar
• Maimone M. M., Tollefsen D. M. Structure of a dermatan sulfate hexasaccharide that binds to heparin co-factor II with high affinity. J. Biol. Chem. 1990; 265: 18263–71
   PubMed Web of Science ®Google Scholar
• Marcum J. A., Rosenberg R. D. The biochemistry, cell biology, and patophysiology of anticoagulantly active heparin-like molecules of the vessel wall. Heparin — chemical and biological properties clinical applications., D. A. Lane, U. Lindahl. CRC Press, Boca Raton 1989a
   Google Scholar
• Marcum J. A., Rosenberg R. D. Role of endothelial cell surface heparin-like polysaccharides. Ann. N.Y. Acad. Sci. 1989b; 556: 81–94
   PubMed Web of Science ®Google Scholar
• Mascarelli F. G. F., Courtois Y. aFGF binding to low and high affinity receptors induces both aFGF and aFGF receptors dimerization. Growth Factors 1993; 8: 211–33
   PubMed Web of Science ®Google Scholar
• Matheson N. K., McCleary B. V. Enzymes metabolizing polysaccharides and their application to the analysis of structure and function of glycans. the polysaccharides., G. O. Aspinall. Academic Press, Orlando 1985
   Google Scholar
• Matzner Y., Vlodavsky I., Bar-Ner M., Ishai-Michaeli R., Tauber A. I. Subcellular localization of heparanase in human neutrophils. J. Leukoc. Biol. 1992; 51: 519–24
   Google Scholar
• McLean M. W., Long W. F., Williamson F. B. Proc. 8th Int. Symp. Glycoconjugates. 1985; 73–74
   Google Scholar
• Michelacci Y. M., Dietrich C. P. A comparative study between a chondroitinase B and a chondroitinase AC from Flavobacterium heparinum. Biochem. J. 1975; 151: 121–29
   PubMed Web of Science ®Google Scholar
• Michelacci Y. M., Dietrich C. P. Chondroitinase C from Flavobacterium heparinum. J. Biol. Chem. 1976; 254: 1154–58
   Google Scholar
• Michelacci Y. M., Horton D. S. P. Q., Poblacion C. A. Isolation and characterization of an induced chondroitinase ABC from Flavobacterium heparinum. Biochim. Biophys. Acta 1987; 923: 291–301
   Google Scholar
• Millane R. P., Mitra K., Amott S. Chondroitin 4-sulfate: comparison of the structures of the potassium and sodium salts. J. Mol. Biol. 1983; 169: 903–20
   PubMed Web of Science ®Google Scholar
• Mitra A. K., Amott S., Atkins E. D. T., Isaac D. H. Dermatan sulfate: molecular conformations and interactions in the condensed state. J. Mol. Biol. 1983; 169: 873–901
   PubMed Web of Science ®Google Scholar
• Moffat C. F., McLean M. W., Long W. F., Williamson F. B. Heparinase II from Flavobacterium heparinum —action on chemically modified heparins. Eur. J. Biochem. 1991a; 197: 449–59
   PubMedGoogle Scholar
• Moffat C. F., McLean M. W., Long W. F., Williamson F. B. Heparinase II from Flavobacterium heparinum: HPLC analysis of the saccharides generated from chemically modified heparins. Eur. J. Biochem. 1991b; 202: 531–41
   PubMedGoogle Scholar
• Morris E. R., Rees D. A., Welsh E. J. Conformation and dynamic interactions in hyaluronate solutions. J. Mol. Biol. 1980; 138: 383–400
   PubMed Web of Science ®Google Scholar
• Mourey L., Samama J.-P., Delarue M., Petitou M., Choay J., Moras D. Crystal structure of cleaved bovine antithrombin III at 3.2 Å resolution. J. Mol. Biol. 1993; 232: 223–41
   Google Scholar
• Mulloy B., Forster M. J., Jones C., Davies D. B. N.m.r. and molecular-modeling studies of the solution conformation of heparin. Biochem J. 1993; 293: 849–58
   PubMed Web of Science ®Google Scholar
• Murata K., Yokoyama Y. Characterization of the products generated from oversulphated dermatan sulphate isomers with chondroitinase-B high-performance liquid chromatography. J. Chrom. 1987; 423: 51–61
   PubMed Web of Science ®Google Scholar
• Nader H. B., Dietrich C. P. Natural Occurence and possible biological role of heparin. Heparin —Chemical and biological properties clinical applications, D. A. Lane, U. Lindahl. CRC Press, Boca Raton 1989; 81–96
   Google Scholar
• Nader H. B., Dietrich C. P., Buonassi V., Colburn P. Heparin sequence in the heparan sulfate chains of an endothelial cell proteoglycan. Proc. Narl. Acad. Sci., USA 1987; 84: 3565–69
   PubMedGoogle Scholar
• Nader H. B., Porcionatto A., et al. Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. J. Biol. Chem. 1990; 265: 16807–13
   PubMed Web of Science ®Google Scholar
• Nakada H. I., Wolfe J. B. Studies on the enzyme chondroitinase: product structure and ion effects. Arch. Biochem. Biophys. 1961; 94: 244–51
   Google Scholar
• Nakagawa H., Yamada T., et al. Isolation and characterization of an endo-β-galactosidase from a new swain of Escherichia freundii. J. Biol. Chem. 1980; 255: 5955–59
   Google Scholar
• Nakajima M., Irimura T., Ferrante N. D., Nicolson G. L. Metastatic melanoma cell heparanase. J. Biol. Chem. 1984; 259: 2283–90
   PubMed Web of Science ®Google Scholar
• Nakajima M., Irimura T., Nicolson G. L. Tumor meastasis-associated heparanase activity in human melanoma cells. Cancer Lett. 1986; 31: 277–83
   Google Scholar
• Nakajima M., Irimura T., Nicolson G. L. Heparanases and tumor metastasis. J Cell. Biochem. 1988; 36: 157–67
   PubMed Web of Science ®Google Scholar
• Nakamura T., Shibata Y., Fujimura S. Purification and properties of Bacteroides heparinolyticusheparinase. J. Clin. Microbiol. 1988; 26: 1070–71
   Web of Science ®Google Scholar
• Nakazawa K., Ito M., Yamagata T., Suzuki S. Substrate specificity of keratan sulphate-degrading enzymes from microorganisms. Keratan Sulphate —Chemistry, Biology, Clinical Pathology., H. Greiling, J. E. Scott. The Biochemical Society, London 1989; 99–110
   Google Scholar
• Nelson R., Ceccconi O., Roberts W., Aruffo A., Linhardt R., Bevilacqua M. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood 1993; 82: 3253–58
   PubMed Web of Science ®Google Scholar
• Nieduszynski I. A. Connective tissue polysaccha-rides. Polysaccharides — Topics in structure and morphology., E. D. T. Atkins. VCH, WeinheimGermany 1985
   Google Scholar
• Nieduszynski I. A., Huckerby T. N., Dickenson J. M., Orown G. M., Gui-Hua T., Bayliss M. T. Structural aspects of skeletal keratan sulphates. Biochem. Soc. Trans. 1990; 18: 792–93
   Google Scholar
• Norgard-Sumnicht K., Varki A. Endothelial heparan sulfate proteoglycans that bind to L-selectin have glucosamine residues with unsubstituted amino groups. J. Biol. Chem. 1995; 270: 12012–24
   PubMed Web of Science ®Google Scholar
• Norgard-Sumnicht K. E., Varki N. M., Varki A. Calcium-dependent heparin-like ligands for L-selectin in nonlymphoid endothelial cells. Science 1993; 261: 480–83
   PubMed Web of Science ®Google Scholar
• Oeben Keller R., Stuhlsatz H. W., Greiling H. Constant and variable domains of different disaccharide structure in corneal keratan sulphate chains. Biochem. J. 1987; 248: 85–93
   Google Scholar
• Ogamo A., Nagai A., Nagasawa K. Binding of heparin fractions and other polysulfated polysaccharides to plasma fibronectin: effects of molecular size and degree of sulfation of polysaccharides. Biochim. Biophys. Acta 1985; 841: 30–41
   Google Scholar
• Oliviero U., Sorrentino G. P., et al. Effects of the treatment with matrix on elderly people with chronic articular degeneration. Drugs. Exp. Clin. Res. 1991; 17: 45–51
   PubMedGoogle Scholar
• Oosta G. M., Favreau L. V., Beeler D. L., Rosenberg R. D. Purification and properties of human platelet heparitinase. J Biol Chem 1982; 257: 11249–55
   PubMedGoogle Scholar
• Ornitz D. M., Herr A. B., Nilsson M., Westrnan J., Svahn C.-M., Waksman G. FGF binding and FGF receptor activation by synthetic heparin-derived di- and ti-saccharides. Science 1995; 268: 432–36
   PubMed Web of Science ®Google Scholar
• Ornitz D. M., Yayon A., Flanagan J. G., Svahn C. M., Levi E., Leder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 1992; 12: 240–47
   PubMed Web of Science ®Google Scholar
• Pantoliano M., Horlick R. A., et al. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 1994; 33: 10229–48
   PubMed Web of Science ®Google Scholar
• Parthasarathy N., Goldberg I. J., Sivaram P., Mulloy B., Flory D. M., Wagner W. D. Oligosaccha-ride sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase. J. Biol. Chem. 1994; 269: 22391–96
   PubMed Web of Science ®Google Scholar
• Pejler G., Bäckström G., et al. Structure and affinity for antithrombin of heparan sulfate chains derived from basement membrane proteoglycans. J. Biol. Chem. 1987a; 262: 5036–43
   PubMed Web of Science ®Google Scholar
• Pejler G., Danielsson Å., Björk I., Lindahl U., Nader H. B., Dietrich C. P. Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasilianuand Tivela mactroides. J. Biol. Chem. 1987b; 262: 11413–21
   PubMed Web of Science ®Google Scholar
• Pickersgill R., Jenkins J., Hanis G., Nasser W., Robert-Baudouy J. The structure of Bacillus subtilispectate lyase in complex with calcium. Structural Biology 1994; 1: 717–23
   PubMedGoogle Scholar
• Poole A. R. Proteoglycans in health and disease: structure and functions. Biochem. J. 1986; 236: 1–14
   PubMed Web of Science ®Google Scholar
• Prehm P. Synthesis of hyaluronate in differentiated teratocarcinoma cells. Biochem. J. 1983; 211: 191–98
   PubMed Web of Science ®Google Scholar
• Prehm P. Hyaluronate is synthesized at plasma membranes. Biochem. J. 1984; 220: 597–600
   PubMed Web of Science ®Google Scholar
• Preston J. F., Rice J. D. Kinetic analysis of pectate lyases by high-performance liquid chromatog-raphy. Carb. Res. 1991; 215: 137–45
   Google Scholar
• Preston J. F., Rice J. D., Chow M. C., Brown B. J. Kinetic comparisons of trimer-generating pectate and alginate lyases by reversed-phase ion-pair liquid chromatography. Carb. Res. 1991; 215: 147–57
   Google Scholar
• Preston J. F., Rice J. D., Ingram L. O., Keen N. T. Differential depolymerization mechanisms of pectate lyases secreted by Erwinia chrysanthemiEC 16. J. Bact. 1992; 174: 2039–42
   PubMed Web of Science ®Google Scholar
• Prestrelski S. J., Fox G. M., Arakawa T. Binding of heparin to basic fibroblast growth factor induces a confor-mational change. Arch. Biochem Biophys. 1992; 293: 314–19
   Google Scholar
• Ragazzi M., Ferro D. R., Perly B., Sinay P., Petitou M., Choay J. Conformation of the pentasaccharide corresponding to the binding site of heparin for antithrombin III. Carb. Res. 1990; 195: 169–85
   Google Scholar
• Ragazzi M., Ferro D. R., Provasoli A. A force-field study of the conformational characteristics of the iduronate ring. J. Comp. Chem. 1986; 7: 105–112
   PubMed Web of Science ®Google Scholar
• Rapneger A. C. The coordinated regulation of heparan sulfate, syndecans and cell behavior. Curr, Op. Cell Biol. 1993; 5: 844–53
   Google Scholar
• Rapraeger A. C., Krufka A., Olwin B. B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991; 252: 1705–08
   PubMed Web of Science ®Google Scholar
• Rautela G. S., Abramson C. Crystallization and partial characterization of Staphylococcus aureufhyaluronate lyase. Arch. Biochem. Biophys. 1973; 158: 687–94
   PubMed Web of Science ®Google Scholar
• Rees D. A., Moms E. R., Stoddart J. F., Stevens E. S. Controversial glycosaminoglycan conformations. Nature 1985; 317: 480
   Google Scholar
• Rees D. A., Moms E. R., Thorn D., Madden J. K. Shapes and interactions of carbohydrate chains. The Polysaccharides., G. O. Aspinall. Academic Press, New York 1982
   Google Scholar
• Rice K. G., Linhardt R. J. Study of structurally defined oligosaccharide substrates of heparin and heparan monosulfate lyases. Carb. Res. 1989; 190: 219–33
   Google Scholar
• Robyt J. F., French D. Multiple attack and polarity of action of procine pancreatic α-amylase. Arch. Biochem. Biophys. 1970; 138: 662–70
   PubMed Web of Science ®Google Scholar
• Roden L., Cambell P., et al. Enzymic pathways of hyaluronan catabolism. the Biology of Hyaluronan. Ciba Foundation, John Wiley & Sons, Chichester, NY 1989; 60–86
   Google Scholar
• Rosenberg R. D. Platelet Heparitinase. Meth. Enzym. 1989; 169: 342–351
   Google Scholar
• Rosengart T. K., Johnson W. V., Friesel T., Clark T., Maciag T. Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro. Biochem. Biophys. Res. Comm. 1988; 152: 432–40
   PubMed Web of Science ®Google Scholar
• Saksela O., Moscatelli D., Sommer A., Rifkin D. B. Endorthelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell. Biol. 1988; 107: 743–51
   PubMed Web of Science ®Google Scholar
• Salyers A. A., Vercellotti J. R., West S. E. H., Wilkins T. D. Fermentation of mucin and plant polysaccharides by strains of bacteroides from the human colon. Appl. Environ. Microbiol. 1977; 33: 319–22
   PubMed Web of Science ®Google Scholar
• Sanderson P. N., Huckerby T. N., Nieduszynski I. A. Chondroitinase ABC digestion of dermatan sulphate. Biochem. J. 1989; 257: 347–54
   Google Scholar
• Sandström J., Carlsson L., Marklund S. L., Edlund T. The heparin-binding domain of extracellular su-peroxide dismutase C and formation of variants with reduced heparin affinity. J. Biol. Chem. 1992; 267: 18205–09
   PubMed Web of Science ®Google Scholar
• Sasisekharan R. Cloning and biochemical characterization of heparinase from Flavobacterium heparinum. Ph.D thesis, Harvard University. 1991
   Google Scholar
• Sasisekharan R., Bulmer M., Moremen K. W., Cooney C. L., Langer R. Cloning and expression of heparinase I gene from Flavobacterium heparinum. Proc. Natl. Acad. Sci., USA 1993; 90: 3660–64
   PubMed Web of Science ®Google Scholar
• Sasisekharan R., Godavarti R., Emst S., Venkataraman G., Cooney C. L., Langer R. Characterization and mapping of heparinase I binding to heparin: identification of a heparin binding sequence. J. Biol. Chem 1995a
   Google Scholar
• Sasisekharan R., Leckband D., Godavarti R., Venkataraman G., Cooney C. L., Langer R. Heparinase I from Flavobacterium heparinum. The role of the cystrine residue in catalysis as probed by chemical modification and site-directed mutagenesis. Biochemistry 1995b; 34, In press
   Google Scholar
• Sasisekharan R., Moses M. A., Nugent M. A., Cooney C. L., Langer R. Heparinase inhibits neovascularization. Proc. Natl. Acad. Sci., USA 1994; 91: 1524–28
   Google Scholar
• Sato N., Murata K., Kimura A. Subunit structure of chondroitinase ABC from Proteus vulgaris. Agric. Biol. Chem. 1986; 50: 1057–59
   Web of Science ®Google Scholar
• Savion N., Disatnik M. H., Nevo Z. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells. J. Cell. Physiol. 1987; 130: 77–84
   PubMed Web of Science ®Google Scholar
• Sawaguchi S., Yue B., Yeh P., Tso M. O. M. Effects of intracameral injection of chondroitinase ABC in vivo. Arch. Ophthalmol. 1992; 110: 110–17
   PubMedGoogle Scholar
• Schreuder H. A., de Boer B., et al. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Nature Structural Biology 1994; 1: 48–54
   Google Scholar
• Scott J. E. Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues. FASEB J 1992; 6: 2639–45
   PubMed Web of Science ®Google Scholar
• Scott J. E., Chen Y., Brass A. Secondary and tertiary structures involving chondroitin and chondroitin sulphates in solution investigated by rotary shadowing/ electron microscopy and computer simulation. Eur. J. Biochem. 1992; 209: 675–80
   PubMedGoogle Scholar
• Scott J. E., Cummings C., Brass A., Chen Y. Secondary and tertiary structures of hyaluronan in aqueous solution investigated by rotary shadowing/electron microscopy and computer simulation. Biochem. J. 1991; 274: 699–705
   PubMed Web of Science ®Google Scholar
• Scott J. E., Heatley F., Jones M. N., Wilkinson A., Olavesen A. H. Secondary structure of chondroitin sulphate in dimethyl sulphoxide. Eur. J. Biochem. 1983; 130: 491–95
   PubMedGoogle Scholar
• Scudder P., Tang P. W., Hounsell E. F., Lawson A. M., Mehmet H., Feizi T. Isolation and characterization of sulphated oligosaccharides released from bovine corneal keratan sulphate by the action of endo-β-galactosidase. Eur. J. Biochem. 1986; 157: 365–73
   Google Scholar
• Sheehan J. K., Gardner K. H., Atkins E. D. T. Hyaluronic acid: a double-helical structure in the presence of potassium at low pH and found also with the cations ammonium, rubidium and caesium. J. Mol. Biol. 1977; 117: 113–35
   PubMed Web of Science ®Google Scholar
• Shieh M.-T., WuDunn D., Montgomeryu R. I., Esko J. D., Spear P. G. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biology 1992; 116: 1273–81
   PubMed Web of Science ®Google Scholar
• Sierks M. R., Ford C., Reilly P. J., Svensson B. Functional roles and subsite locations of Leu 177, Trp 178 and Asn 182 of Aspergillus awamoriglucoamylase determined by site-directed mutagenesis. Protein Eng 1993; 6: 75–79
   Google Scholar
• Silva M. E., Dietrich C. P., Nader H. B. On the structure of heparitin sulfates. Biochim. Biophys. Acta. 1976; 437: 129–41
   Google Scholar
• Silverberg I., Havsmark B., Fransson L.-A. The substrate specificity of heparin sulphate lyase and hep-arin from Flavobacterium heparinum. Carb. Res. 1985; 137: 227–38
   Web of Science ®Google Scholar
• Sjøgren P., Pedersen T., Steinmetz H. Mucopolysaccharidoses and anaesthetic risks. Acta. Anaesthesiol. Scand. 1987; 31: 214–18
   Google Scholar
• Sommer A., Rifkin D. B. Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan. J. Cell. Phys. 1989; 138: 215–20
   PubMed Web of Science ®Google Scholar
• Spom M. B., Roberts A. B. Peptide Growth Factors and Their Receptors. Springer-Verlag, Berlin 1990
   Google Scholar
• Springer B. A., Pantoliano M. W., et al. Identification and concerted function of two receptor binding sufaces on basic fibroblast growth factor required for mitogenesis. J. Biol. Chem. 1994; 269: 26879–84
   PubMed Web of Science ®Google Scholar
• Steyn P. L., Pot B., Segers P., Kersters K., Joubert J. J. Some novel aerobic heparin-degrading bacterial isolates. System. Appl. Microbiol. 1992; 15: 137–43
   Google Scholar
• Stoddart J. F. Stereochemistry of carbohydrates. John Wiley and Sons, New York 1971
   Google Scholar
• Stuhlsatz H. W., Hirtzel F., Keller R., Cosma S., Greiling H. Studies on the polydispersity and heterogeneity of proteokeratan sulfate from calf and porcine cornea. Hoppe-Seyler'sZ. Physiol Chem 1981; 362: 841–52
   Google Scholar
• Stuhlsatz H. W., Keller R. Strucuture of keratan sulphate proteoglycans: core proteins, linkage regions, carbohydrate chains. Keratan Sulphate —Chemistry, Biology, Clinical Pathology., H. Greiling, J. E. Scott. The Biochemical Society, London 1989; 1–11
   Google Scholar
• Takegawa K., Iwahara K., Iwahara S. Purification and properties of chondroitinase produced by a bacterium isolated from soil. J. Fenn. Bioeng. 1991; 72: 128–31
   Google Scholar
• Tam Y.-C., Chan E. C. S. Purification and characterization of hyaluronidase from oral Peptostreptococcusspecies. Infect. Imm. 1985; 47: 508–13
   PubMed Web of Science ®Google Scholar
• Taylor R. L., Shively J. E., Conrad H. E., Cifonelli J. A. Uronic acid composition of heparins and heparan sulfates. Biochemistry 1973; 12: 3633–37
   PubMed Web of Science ®Google Scholar
• Tejidor L., Oman D., et al. Use of DADE hepzyme to eliminate heparin interference in coagulation testing. Thromb. Hemostasis 1993; 69: 866
   Google Scholar
• Thompson L. D., Pantoliano M. W., Springer B. A. Energetic characterization of the basic fibroblast growth factor-heparin interaction: Identification of the heparin binding domain. Biochemistry 1994; 33: 3831–40
   PubMed Web of Science ®Google Scholar
• Thornton D. J., Morris H. G., et al. Structural and immunological studies of keratan sulphates from mature bovine articular cartilage. Biochem. J. 1989; 260: 277–82
   PubMed Web of Science ®Google Scholar
• Thunberg L., Backstrom G., Wasteson Å., Robinson H. C., Ogren S., Lindahl U. Enzymatic depoly-merization of heparin-related polysaccharides. J. Biol. Chem. 1982; 257: 10278–82
   Google Scholar
• Thurston C. F., Hardingham T. E., Muir H. The kinetics of degradation of chondroitin sulphates and hyaluronic acid by chondroitinase from Proteus vulgaris. Biochem. J. 1975; 145: 397–400
   Google Scholar
• Tollefsen D. M. The interaction of glycosaminogly-cans with heparin cofactor 11: structure and activity of a high-affinity dermatan sulfate hexasaccharide. Heparin and related polysaccharides., D. A. Lane, I. Björk, U. Lindahl. Plenum Press, New York 1992
   Google Scholar
• Torgerson E. M., Brewer L. C., Thoma J. A. Subsite mapping of enzymes. Use of subsite map to simulate complete time course of hydrolysis of a polymeric substrate. Arch. Biochem. Biophys. 1979; 196: 13–22
   PubMed Web of Science ®Google Scholar
• Turnbull J. E., Fernig D. G., Ke Y., Wilkinson M. C., Gallagher J. T. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J. Biol. Chem. 1992; 267: 10337–41
   PubMed Web of Science ®Google Scholar
• Turnbull J. E., Gallagher J. T. Distribution of iduronate 2-sulphate residues in heparan sulphate. Biochem. J. 1991a; 273: 553–59
   PubMed Web of Science ®Google Scholar
• Turnbull J. E., Gallagher J. T. Sequence analysis of heparan sulphate indicates defined location of N-sulphated glucosamine and iduronate 2-ulphate residues proximal to the protein-linkage region. Biochem. J. 1991b; 277: 297–303
   Google Scholar
• Tyrrell D. J., Isihara M., et al. Strucutre and affinity of a heparin-derived hexaccharide with high affinity for basic fibroblast growth factor. J. Biol. Chem. 1993; 268: 4684–89
   PubMed Web of Science ®Google Scholar
• Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993; 3: 97–130
   PubMed Web of Science ®Google Scholar
• Venkataraman G., Sasisekharan V., Cooney C. L., Langer R., Sasisekharan R. A stereochemical approach to pyranose ring flexibility: Its implications for the conformation of dermatan sulfate. Proc. Natl. Acad. Sci., USA 1994; 91: 6171–75
   Google Scholar
• Vesterberg O. Studies on extracellular proteins from Sraphylococcus aureus. III. Investigations on the heterogeneity of hyaluronate lyase using the method of isoelec-tric focusing. Biochim. Biophys. Acta 1968; 168: 218–27
   Google Scholar
• Vlodavsky I., Eldor A., et al. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 1992; 12: 112–27
   PubMedGoogle Scholar
• Vlodavsky I., Fuks Z., et al. Extracellular matrixresident basic fibroblast growth factor: Implication for the control of angiogenesis. J. Cell. Biochem. 1991; 45: 167–76
   PubMed Web of Science ®Google Scholar
• Walenga J. W., Hoppensteadt D., Fareed J. Non-heparin glycosaminwlycan-derived drugs: A biochemical and pharmacologic perspective. Sem. Thromb. Hem. 1991; 17(suppl 1)137–42
   Google Scholar
• Ward O. P., Moo-Young M. Enzymatic degradation of cell wall and related plant polysaccharides. CRC Critical Rev Biotechnology 1989; 8: 237–74
   PubMed Web of Science ®Google Scholar
• Wasteson Å., Glimelius B., Busch C., Westermark B., Heldin C.-H., Norling B. Effect of a platelet endoglycosidase on cell surface associated heparan sulphate of human cultured endothelial and glial cells. Thromb. Res. 1977; 11: 309–21
   Google Scholar
• Wasteson Å., Westermark B. Demonstration of a platelet enzyme degrading heparan sulphate. FEBS Letters 1976; 64: 218
   PubMed Web of Science ®Google Scholar
• Winter W. T., Taylor M. G., Stevens E. S., Moms E. R., Rees D. A. Biochem. Biophys. Res. Comm. 1986; 137: 87–93
   Google Scholar
• Yamada S., Yoshida K., et al. Structural studies on the bacterial lyase-resistant tetrasaccharides derived from the antithrombin III-binding site porcine intestinal hep-arin. J Biol Chem 1993; 268: 4780–87
   Google Scholar
• Yamagata T., Saito H., Habuchi O., Suzuki S. Purification and properties of bacterial chondroitinases and chondrosulfatases. J. Biol. Chem. 1968; 243: 1523–35
   PubMed Web of Science ®Google Scholar
• Yanagishita. Metabolism of plasma membrane-associated heparan sulphate proteoglycans. Heparin and related polysaccharides., D. A. Lane, I. Bjork, U. Lindahl. Plenum hess, New York 1989
   Google Scholar
• Yang V. C., Linhardt R. J., Bernstein H., Cooney C. L., Langer R. Purification and characterization of heparinase from Flavobacterium heparinum. J. Biol. Chem. 1985; 260: 1849–57
   PubMed Web of Science ®Google Scholar
• Yayon A., Klagsbrun M., Esko J. D., Leder P., Ornitz D. M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841–48
   PubMed Web of Science ®Google Scholar
• Yoder M. D., Keen N. T., Jumak F. New domain motif the structure of pectate lyase C, a secreted plant virulence factor. Science 1993a; 260: 1503–07
   PubMed Web of Science ®Google Scholar
• Yoder M. D., Lietzke S. E., Jumak F. Unusual structural features in the parallel b-helix in pectate lyases. Structure 1993b; 1: 241–51
   PubMed Web of Science ®Google Scholar
• Yost H. J. Regulation of vertebrate left-right asymmetries by extracellular matrix. Nature 1992; 357: 158–61
   PubMed Web of Science ®Google Scholar
• Zern M. A., Reid L. M. Extracellular Matrix. Marcel Dekker, New York 1993
   Google Scholar
• Zhang J., Cousens L. S., Barr P. J., Sprang S. R. Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin lβ. Proc. Natl. Acad. Sci., USA 1991; 88: 3446–50
   PubMed Web of Science ®Google Scholar
• Zhu X., Hsu B. T., Rees D. C. Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor. Structure 1993; 1: 27–34
   PubMedGoogle Scholar
• Zhu X., Komiya H., et al. Three-dimensional structures of acidic and basic fibroblast growth factors. Science 1991; 251: 90–93
   PubMed Web of Science ®Google Scholar